Prohemostatic proteins for the treatment of bleeding
US-2024390467-A1 · Nov 28, 2024 · US
Factor VII composition
US9029316B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9029316-B2 |
| Application number | US-201013377680-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2010 |
| Priority date | Jun 26, 2009 |
| Publication date | May 12, 2015 |
| Grant date | May 12, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to a stable pharmaceutical composition in liquid form or in solid form, comprising factor VII, said composition being free of mannitol and of sucrose, or even also of any antioxidant.
First claim
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition in liquid form or in solid form, comprising factor VII, arginine, isoleucine, lysine, glycine, and trisodium citrate or calcium chloride, wherein said composition is free of mannitol, glycylglycine, and sucrose; and the factor VII is in activated form and is obtained by genetic engineering from cells or from transgenic animals. 2. The composition according to claim 1 , wherein the composition is in li…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9029316B2 cover?
- The invention relates to a stable pharmaceutical composition in liquid form or in solid form, comprising factor VII, said composition being free of mannitol and of sucrose, or even also of any antioxidant.
- Who is the assignee on this patent?
- Bardat Annie, Pompe Cornelius, Lab Francais Du Fractionnement
- What technology area does this patent fall under?
- Primary CPC classification A61K38/4846. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).